Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
2.980
+0.110 (3.83%)
At close: Sep 22, 2026, 4:00 PM EDT
3.100
+0.120 (4.03%)
After-hours: Sep 22, 2026, 7:58 PM EDT
Jupiter Neurosciences Revenue
Jupiter Neurosciences had revenue of $24.25K in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $64.69K. In the year 2025, Jupiter Neurosciences had annual revenue of $21.80K.
Revenue (ttm)
$64.69K
Revenue Growth
n/a
P/S Ratio
60.94
Revenue / Employee
$12,939
Employees
5
Market Cap
3.93M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 21.80K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 233.28K | -404.76K | -63.44% |
| Dec 31, 2021 | 638.04K | -488.20K | -43.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| HCW Biologics | 6.72M |
| PMGC Holdings | 2.58M |
| 60 Degrees Pharmaceuticals | 1.21M |
| BioRestorative Therapies | 357.87K |
| VivoSim Labs | 112.00K |
JUNS News
- 4 weeks ago - Why Is Penny Stock Jupiter Neurosciences (JUNS) Up Today? - TipRanks
- 4 weeks ago - Jupiter Neurosciences announces pricing of $2M registered direct offering - TheFly
- 4 weeks ago - Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering - GlobeNewsWire
- 4 weeks ago - Jupiter Neurosciences Inc trading resumes - TheFly
- 4 weeks ago - Jupiter Neurosciences Inc trading halted, volatility trading pause - TheFly
- 6 weeks ago - Jupiter Neurosciences Inc trading halted, news pending - TheFly
- 6 weeks ago - Jupiter Neurosciences announces 1-for-75 reverse stock split - TheFly
- 6 weeks ago - Jupiter Neurosciences, Inc. Announces Reverse Stock Split - GlobeNewsWire